215 related articles for article (PubMed ID: 33662773)
1. Low levels of Lysosomal Acid Lipase (LAL) activity increases necroinflammation in adult patients with biopsy-proven metabolic associated fatty liver disease.
Thoen RU; Longo L; Neto SC; Álvares-da-Silva MR
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101638. PubMed ID: 33662773
[TBL] [Abstract][Full Text] [Related]
2. Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.
Baratta F; Pastori D; Del Ben M; Polimeni L; Labbadia G; Di Santo S; Piemonte F; Tozzi G; Violi F; Angelico F
EBioMedicine; 2015 Jul; 2(7):750-4. PubMed ID: 26288848
[TBL] [Abstract][Full Text] [Related]
3. Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients.
Selvakumar PK; Kabbany MN; Lopez R; Tozzi G; Alisi A; Alkhouri N; Nobili V
Dig Liver Dis; 2016 Aug; 48(8):909-13. PubMed ID: 27198736
[TBL] [Abstract][Full Text] [Related]
4. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.
Baratta F; Pastori D; Tozzi G; D'Erasmo L; Di Costanzo A; Arca M; Ettorre E; Ginanni Corradini S; Violi F; Angelico F; Del Ben M
Liver Int; 2019 Dec; 39(12):2301-2308. PubMed ID: 31392821
[TBL] [Abstract][Full Text] [Related]
6. Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell cultures.
Gomaraschi M; Fracanzani AL; Dongiovanni P; Pavanello C; Giorgio E; Da Dalt L; Norata GD; Calabresi L; Consonni D; Lombardi R; Branchi A; Fargion S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158523. PubMed ID: 31505261
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal Acid Lipase Activity in Non-alcoholic Fatty Liver Disease as a Novel Diagnostic and Therapeutic Target: A Systematic Literature Review of Current Evidence and Future Directions.
Bashir A; Duseja A; Verma A; De A; Tiwari P
J Clin Exp Hepatol; 2022; 12(6):1535-1546. PubMed ID: 36340307
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
[TBL] [Abstract][Full Text] [Related]
9. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.
Angelico F; Corradini SG; Pastori D; Fargion S; Fracanzani AL; Angelico M; Bolondi L; Tozzi G; Pujatti PL; Labbadia G; Corazza GR; Averna M; Perticone F; Croce G; Persico M; Bucci T; Baratta F; Polimeni L; Del Ben M; Violi F;
Atherosclerosis; 2017 Jul; 262():179-184. PubMed ID: 28396038
[TBL] [Abstract][Full Text] [Related]
10. Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
Ferri F; Mischitelli M; Tozzi G; Messina E; Mignini I; Mazzuca S; Pellone M; Parisse S; Marrapodi R; Visentini M; Baratta F; Del Ben M; Pastori D; Perciballi R; Attilia ML; Carbone M; De Santis A; Violi F; Angelico F; Ginanni Corradini S
Clin Transl Gastroenterol; 2020 Feb; 11(2):e00116. PubMed ID: 32463622
[TBL] [Abstract][Full Text] [Related]
11. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.
Polimeni L; Pastori D; Baratta F; Tozzi G; Novo M; Vicinanza R; Troisi G; Pannitteri G; Ceci F; Scardella L; Violi F; Angelico F; Del Ben M
Intern Emerg Med; 2017 Dec; 12(8):1159-1165. PubMed ID: 28900817
[TBL] [Abstract][Full Text] [Related]
12. A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.
Tovoli F; Napoli L; Negrini G; D'Addato S; Tozzi G; D'Amico J; Piscaglia F; Bolondi L
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587063
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?
Gravito-Soares M; Gravito-Soares E; Gomes D; Tome L
Ann Hepatol; 2019; 18(1):78-88. PubMed ID: 31113613
[TBL] [Abstract][Full Text] [Related]
14. The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.
Yang RX; Zou ZS; Zhong BH; Deng H; He FP; Shi JP; Zhao CY; Mi YQ; Zhou YJ; Di FS; Zheng RD; Du Q; Shang J; Popovic B; Chen J; Fan JG
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):426-432. PubMed ID: 34246549
[TBL] [Abstract][Full Text] [Related]
15. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2.
Hamilton J; Jones I; Srivastava R; Galloway P
Clin Chim Acta; 2012 Aug; 413(15-16):1207-10. PubMed ID: 22483793
[TBL] [Abstract][Full Text] [Related]
16. Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease.
Shteyer E; Villenchik R; Mahamid M; Nator N; Safadi R
Int J Mol Sci; 2016 Feb; 17(3):312. PubMed ID: 26927097
[TBL] [Abstract][Full Text] [Related]
17. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
Bradić I; Liesinger L; Kuentzel KB; Vujić N; Trauner M; Birner-Gruenberger R; Kratky D
J Lipid Res; 2023 Sep; 64(9):100427. PubMed ID: 37595802
[TBL] [Abstract][Full Text] [Related]
18. Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Guerreiro GTS; Longo L; Fonseca MA; de Souza VEG; Álvares-da-Silva MR
Hepatol Int; 2021 Apr; 15(2):380-391. PubMed ID: 33694066
[TBL] [Abstract][Full Text] [Related]
19. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver.
Carotti S; Lettieri-Barbato D; Piemonte F; Ruggiero S; Rosina M; Zalfa F; Zingariello M; Arciprete F; Valentini F; Francesconi M; D'Amico J; De Vincentis A; Baiocchini A; Perrone G; Antonelli-Incalzi R; Morini S; Picardi A; Aquilano K; Vespasiani-Gentilucci U
Cell Death Dis; 2021 Nov; 12(12):1092. PubMed ID: 34795230
[TBL] [Abstract][Full Text] [Related]
20. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.
van Kleef LA; Choi HSJ; Brouwer WP; Hansen BE; Patel K; de Man RA; Janssen HLA; de Knegt RJ; Sonneveld MJ
JHEP Rep; 2021 Oct; 3(5):100350. PubMed ID: 34557660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
